Document is current

Article History

Received: 16 June 2022

Accepted: 14 August 2022

First Online: 30 August 2022

Declarations

:

: The authors declare no competing interests.

: JG declares he has received honoraria for advisory consulting and speaking role from Lilly, Servier and BMS. PJF declares she has received honoraria for advisory consulting and speaking from Lilly, MSD and BMS. VA declares she has received honoraria for advisory consulting and speaking role from Lilly, MSD and BMS. AFM declares she has received honoraria for advisory consulting and speaking role from Lilly, Servier, Pierre Fabre, Merck, MSD and BMS. RVT declares she has received honoraria for advisory consulting and speaking from Amgen, Merck, Sanofi, Servier, Bristol-MS, Bayer and Roche and has received support for educational, scientific activities and travel from Amgen, Roche, Lilly, Sanofi, Bristol-MS, Pierre-Fabre and Servier. The other authors declare that they have no conflict of interest regarding the scope of this article.

: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or a substitute for it was obtained from all patients before they were included in the study. Ethics committee Hospital General Universitario Morales Meseguer approved the study (C.P.AGAMENON-C.I.EST:30/14, 26 November 2014).